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Abstract
Background
Healthcare providers’ (HCPs) recommendations for the Human Papillomavirus (HPV) vaccine are likely to increase the vaccination uptake. However, little is known about Ghanaian
HCPs’ general practices regarding HPV vaccination. We used Multi-Theory Model (MTM)
constructs (i.e. participatory dialogue, behavioral confidence, environment, social and emotional transformation) to examine Ghanaian HCPs’ attitudes towards HPV vaccination and
their vaccination recommendation practices.

Received: March 5, 2020
Accepted: September 30, 2020
Published: October 16, 2020
Peer Review History: PLOS recognizes the
benefits of transparency in the peer review
process; therefore, we enable the publication of
all of the content of peer review and author
responses alongside final, published articles. The
editorial history of this article is available here:
https://doi.org/10.1371/journal.pone.0240657
Copyright: © 2020 Agyei-Baffour et al. This is an
open access article distributed under the terms of
the Creative Commons Attribution License, which
permits unrestricted use, distribution, and
reproduction in any medium, provided the original
author and source are credited.
Data Availability Statement: All relevant data are
within the manuscript and its Supporting
Information file.

Methods
We conducted three, 60-minute focus group discussions (FGDs) with HCP in the secondlargest government hospital in Ghana. Sixteen semi-structured open-ended questions
based on MTM constructs were used to guide the FGDs. We explored HCPs’ general knowledge about HPV, vaccination recommendation behavior, physical environment, and sociocultural factors associated with the HPV vaccination. Data from the FGDs were transcribed
and thematically coded using NVivo software.

Results
The sample of (n = 29) HCPs consisting of males (n = 15) and females (n = 14) between the
ages of 29 and 42 years participated in the FGDs. Our analyses showed that HCPs (a)
rarely offered HPV vaccination recommendations, (b) showed varied understanding about
who should be vaccinated regarding age eligibility, gender, and infection status. Perceived
barriers to HPV vaccination include (a) low urgency for vaccination education due to competing priorities such as malaria and HIV/AIDS; (b) lack of data on HPV vaccination; (c) lack
of awareness about the vaccine safety and efficacy; (c) lack of HPV vaccine accessibility
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and (d) stigma, misconceptions and religious objections. HCPs expressed that their motivation for counseling their clients about HPV vaccination would be increased by having more
knowledge about the vaccine’s efficacy and safety, and the involvement of the parents,
chiefs, churches, and opinion leaders in the vaccination programs.

Conclusion
The study’s findings underscore the need for a comprehensive HPV vaccination education
for HCPs in Ghana. Future HPV vaccination education programs should include information
about the efficacy of the vaccine and effective vaccination messages to help mitigate HPV
vaccine-related stigma.

Introduction
Human Papillomavirus (HPV) causes several cancers, including cervical, anal, penile, and oropharyngeal cancer, as well as genital warts and recurrent respiratory papillomatosis [1]. HPVrelated cancers exert disproportionate human suffering and economic burden on Low- and
Middle-Income countries (LMICs) including Ghana. The HPV related cancers represent
unmet medical needs in Ghana, where there were over 3,300 new cases of HPV-related cancers
and 2,977 HPV-related cancer deaths in 2018 [2]. HPV-related cancers accounted for almost
20% of cancer deaths in Ghana [2]. These data show that HPV diseases are a menace to public
health in LMICs in general and Ghana in particular.
HPV vaccines (Cervarix1, Gardasil1, and Gardasil 91) have strong and demonstrated efficacy for protecting against HPV-related diseases in other countries. The availability of these
vaccines has been associated with a decrease in HPV related cancers including cervical dysplasia, the precursor of cervical cancer [3–6]. The World Health Organization (WHO) recommends two doses of vaccination for youths between the ages of 9 and 14 years old [3,7–10].
However, three doses are recommended for both males and females aged 15 through 26 years
who have not been previously vaccinated [11]. In Ghana, the HPV vaccination was first introduced in 2013 [12] and currently, both Cervarix1 and Gardasil1, are sold in the Ghana market. However, in Ghana, like many LMICs, the vaccination rates remain very low [13]. In
2013, the Global Alliance for Vaccines and Immunizations (GAVI) [14,15] and the GARDASIL1 Access Program (GAP) [15], successfully pilot-tested HPV vaccination programs in
Ghana. Since then there is a limited effort to increase the HPV vaccination uptake in Ghana. A
compounding challenge is the lack of HPV vaccination uptake data in Ghana, [16–18] making
it difficult to target priority areas and evaluate vaccination programs. Currently, in Ghana
HPV vaccination is not a government mandated program. Ghana health services (GHS) are
responsible for the distribution of the HPV vaccination in the communities. Besides, a few designated polyclinics (e.g. Komfo Anokye Teaching Hospital in Kumasi) and hospitals (e.g. Suntresu Hospital in Kumasi) are responsible for women’s health which includes HPV
vaccination. There is no health insurance coverage for HPV vaccination (M., Commeh, personal communication, July 20, 2019).
Studies in other countries showed that Healthcare providers (HCPs) including physicians,
nurses, and allied health workers play a central role in HPV vaccine uptake [19–21]. HCPs’
recommendations, referral, reminders or/and counseling for the vaccine is/are associated with
parental decisions to vaccinate their child [22] and the general increase in the vaccination
uptake [23,24]. Research in other settings indicates that multiple factors influence HCPs’ HPV
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vaccination recommendation practices including HCPs’ perceived effectiveness of the HPV
vaccines in reducing cervical cancer [25], HCPs’ perceived behavioral control, self-efficacy,
outcome expectancy and confidence to address parents’ concerns [22,26], and the value placed
on professional organizations recommendations [25,27,28]. However, little is known about
Ghanaians HCPs’ beliefs and attitudes towards the vaccination. Here we identified factors that
influence Ghanaian HCPs’ general practices including general knowledge about HPV, vaccination recommendation behavior, physical environment, and socio-cultural factors about
HPV vaccinations. We also examined HCPs’ perceptions of factors that could encourage
parents and adolescents to participate in HPV vaccination. Understanding Ghanaian HCPs’
predisposing, enabling and reinforcing factors and their general professional practices regarding the HPV vaccine is important for developing evidence-based interventions to improve the
consistency and strength of HPV vaccine recommendation behaviors among HCPs. We
applied the Multi-theory Model of behavior change (MTM) to gain an understanding of Ghanaian HCPs’ HPV vaccination practices.

Theoretical framework
Focus group development and analysis were guided by the multi-theory-model (MTM) of
behavior change. This theoretical framework has two main components: initiation of the
behavior changes and continuation of the health behavior change. The initiation of behavior
change includes; participatory dialogue (individuals weigh advantages versus disadvantages),
behavioral confidence, and changes in the physical environment [29]. The continuation or sustenance of behavior involves; emotional transformation, practice for change, and changes in
the social environment [29]. Theoretically based studies to understand Ghanaian HCPs’ attitudes and behavior towards HPV vaccination are limited and this study seeks to close the gap
in the literature.

Methods
Study setting and participants
We recruited the HCPs in May 2020 from Ghana Health Services (GHS) and the Komfo Anokye Teaching Hospital, the second-largest government hospital in Kumasi, in the Ashanti
Region of Ghana. A purposive sampling strategy was used in the recruitment processes to
ensure a diversity of perspectives based on HCPs’ specialty and departmental settings. The
inclusion criteria were a healthcare provider (physician, nurse, hospital administrator) who
was 18 years or above, worked at GHS and any HPV vaccination designated poly clinics and
hospitals in Kumasi in the Ashanti Region, able to speak English, and was willing to participate
in the study. The inclusion of health professionals other than those who have direct contacts
with patients is necessary for obtaining HPV vaccination information from diverse perspectives. Exclusion criteria were providers (physician, nurse, hospital administrator) who do not
work in any of the HPV vaccination designated hospitals or clinic in Kumasi, Ashanti Region.
We recruited HCP participants through face-to-face contacts and verbal invitations at the hospital and GHS in Kumasi. The research field coordinator went to the GHS (they are officially
responsible to go to the communities to vaccinate adolescents) office in Kumasi in the Ashanti
Region, met with individuals in their offices and introduced the study to them. After questions
from the prospective participants about the study and clarification by the research field coordinator, the prospective participants who met the inclusion criteria and indicated willingness to
participate were given a specific date and time for the focus group discussions. We recruited
participants from the poly clinics (Komfo Anokye Teaching Hospital through the field coordinator visiting the midwifery departments (the designated entities in the clinic to administer
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HPV vaccination), introducingthe study to the doctors and nurses, and gaving a verbal invitation to them to join the focus group. The participants were also given the specific date and
time for the focus group discussions. On the agreed dates and times, the field coordinator
physically went back to remind the invited health professionals from both GHS and the hospital of the focus group discussions.

Sampling
Glaser and Strauss [30] suggested that sample size for qualitative study should be determined
by saturation point. However, Bertaux [31] argued that a minimum of 15 participants is an
acceptable sample size for a qualitative study. In the current study conscious efforts were made
to recruit 29 health professionals from GHA and Komfo Anokye Teaching Hospital so as to
gather more representative data.

Ethical considerations
The study’s protocol was approved by the Institutional Review Boards (IRBs) of Baylor University and Kwame Nkrumah University of Science and Technology in Ghana. We asked the participants to provide oral consent in this study. No written consent was used in this study
because we considered the use of oral consent as a culturally appropriate way of obtaining consent [32,33]. Had either of the IRBs objected to the use of oral consent, we would have considered the written consent but both IRBs agreed oral consent was appropriate At the beginning
of each of the focus group discussions, the principal investigator read the informed consent
aloud to the participants, gave them a chance to ask any questions or voice concerns about participating in the study, and they asked the participants to indicate their willingness to participate by responding “yes” or “no.” In the end, each of the invited participants provided oral
consent (by responding yes) before joining the study. Informed consent form, which was read
orally, is available in the supporting information file.Data collection procedure.
We conducted three, sixty-minute, focus group discussions with HCPs. The focus group
discussions were conducted by the field coordinator (AD) and the principal investigator
(MA). We did not conduct a sample size or power calculation. Based on a literature review
[30,31], we used saturation point as the determinant for sample size. Ahead of the focus
groups, participants answered a brief demographic survey indicating age, gender, education,
marital status, insurance status, religion and job title. All the focus group discussions were conducted at the Komfo Anokye Teaching Hospital research library. For the focus groups, each
participant was assigned a number, sat in a circle and answered questions in a round-robin
format, that is, the participants taking turns to respond to the questions. The discussion guide
consisted of sixteen semi-structured open-ended questions based on MTM constructs, with
additional follow-up questions added for clarifications. We elicited information about participatory dialogue (individuals weigh advantages versus disadvantages), behavioral confidence,
changes in the physical environment, emotional transformation, practice for change, and
changes in the socio-cultural factors associated with the HPV vaccination from the HCPs.
Additionally, we explored general knowledge about HPV vaccination and HCPs’ vaccination
recommendation behaviors. All the discussions were audio-recorded with a hand-held digital
recorder and they were independently transcribed verbatim by two of the researchers (MA
and AA).

Data analysis
Data were evaluated through directed content analysis [34], which is utilized when a theory is
used to understand a phenomenon. The process includes identifying key concepts or variables

PLOS ONE | https://doi.org/10.1371/journal.pone.0240657 October 16, 2020

4 / 16

PLOS ONE

Human papillomavirus vaccination practices and perceptions among Ghanaian Healthcare Providers

as initial coding categories and operational definitions for each category are determined using
the theoretical constructs. Two of the researchers (MA and CM) independently read the transcripts and highlighted all text that on the first impression appeared to represent the MTM
constructs. We coded all the highlighted passages using the predetermined codes based on the
MTM constructs including participatory dialogue behavioral confidence, changes in the physical environment, emotional transformation, practice for change, and changes in the socio-cultural factors. We gave a new code to any text that could not be categorized with the initial
coding scheme. We came together and discussed our individual codes and created a consensus
list of preliminary codes. Preliminary coded transcripts were discussed in an iterative manner
to ensure general agreement and subcategories (themes) were created and coded under each of
the MTM constructs using NVivo 12 Plus. We resolved any disagreement through discussions
and each theme was reported with supporting direct quote(s). In this manuscript, quotes are
summarized in a table. In the text, we denote a number (e.g. 1) and a letter (e.g. a) where the
number represents a subheading for the MTM construct and the letter represents themes identified within each subheading. The number and the letter referred to in the text denote the
direct quotes in the table.

Results
Demographic characteristics
Of the total participants in the study (n = 29), 31.03% were physicians, 27.59% nurses, 17.24%
immunization field officers, and 24.14%other healthcare professionals (biostatisticians, pharmacists, hospital administrator, etc.). Half of the participants were (51%) were males. The
mean age of the participants 35.24 ± 4.10 years. Participants with undergraduate degrees comprised a slight majority (51.72%). The basic demographic characteristics of the participants are
described in Table 1.

Main findings
The main discussions centered on knowledge about the HPV virus and the vaccination. The
interview themes within the Multi-Theory Model constructs and participants’ direct quotes
are presented in Table 2.
Knowledge about HPV. The HCPs were aware of HPV transmission mode and its related
health consequences (Table 2, quote 1a). It was commonly understood among the groups that
HPV is sexually transmitted, and that HPV virus causes genital warts and cancers (example
anal, cervical, oral). However, the HCPs did not know about the health burden of HPV cases
in Ghana because they reported that there is no epidemiological data indicating the prevalence,
incidence, morbidity, and mortality of HPV related diseases. They indicated that HPV-related
diseases are aggregated with other viral-related diseases and that is part of the reasons why
data are not available on HPV health burden in Ghana (1b).
Knowledge about HPV vaccinations. We assessed the HCPs’ general knowledge about
HPV vaccinations including the recommended series of doses, the target population (male
and/or female) and age eligibility and the vaccine importance. The HCPs’ response showed
varied understanding about who should be vaccinated especially about at what age eligibility,
gender, and infection status (positive vs. negative) were the main factors in the response variations. The HCPs’ responses about the target population for HPV vaccination included only
girls aged 11–12 years old, only immunocompromised persons, and everyone even including
children. They indentified HPV sreening as a pre-condition for HPV vaccination. Three doses
were nearly unanimously recognized as the typical quantity of doses for the HPV vaccine (2a2e).
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Table 1. Demographic characteristics of the participants (n = 29).
Variable

Frequency

Percentage

Mean = 35.24

SD = 4.10

Male

15

51.72

Female

14

48.28

Married

21

72.41

Never married

8

27.59

High School

1

3.5

Undergraduate

15

51.72

Graduate

13

44.83

Age
Gender

Marital Status

Education

Annual Income
<20,000

10

34.48

20,000–30,000

16

55.17

35,000–50,000

3

10.34

Christianity

27

93.10

Other

2

6.90

Yes

100

100

No

0

0

Religion

Insurance

Profession
Physician

9

31.03

Nurses

8

27.59

Immunization field officer

5

17.24

Other

7

24.14

https://doi.org/10.1371/journal.pone.0240657.t001

Initiation of communication. Two themes emerged under HCPs’ general practices of initiating HPV vaccination communication and recommendation. The first theme is education
and counseling during a family planning center visit (3a-3b). HCPs in the family care center at
the hospital reported that they include the HPV vaccination education for an adolescent only
when they know that adolescent is sexually active. Again, they counseled patients about HPV
vaccination only when patients are seeking treatment for other reproductive related care or
when a patient is showing symptoms of HPV infections.
The second theme was limited or no HPV vaccination communication due to the competing health priorities (3c-3f). HCPs explained that they concentrate on the acute health issues
and have limited time for preventive care. Other barriers include HPV vaccination is less priority because of lack of awareness and evidence to support efficacy and safety, and/or unavailability of resources (immunization kits), and lack of evidence to support the association
between the HPV infection and cancer. Furthermore, HCPs reported that they do not recommend HPV vaccination because, for the most part, health care in the low-and middle-income
countries like Ghana is episodic and related to acute illness.
Participatory dialogue. HCPs identified several reasons (advantages) that could encourage the HPV vaccination uptake (4a-4b). They include personal beliefs that the HPV vaccine
prevents HPV infection, resulting in financial saving (prevention cost vs. treatment cost),
building the adolescent antibodies to help them build their immune system against HPV infections, reducing morbidity and mortality associated with HPV related diseases.

PLOS ONE | https://doi.org/10.1371/journal.pone.0240657 October 16, 2020

6 / 16

PLOS ONE

Human papillomavirus vaccination practices and perceptions among Ghanaian Healthcare Providers

Table 2. Interview themes within the multi-theory model constructs, and participants’ quotes.
Constructs

Themes

Quote

1. HPV Knowledge

(a) Transmission

“I have heard about the HPV virus as a type of virus that can cause cervical cancer and also other types of
cancer. I also heard that it can be transmitted sexually. And also, during childbirth, it can also be transmitted
from the mother to the infant.” (Group 1, Participant 2).

(b) Lack of Data

“We don’t have data specifically on HPV. I think once it is viral, it mimics characteristics of any other viral so
I think we just lump them together and reporting is a problem so if education goes up and the reporting
patterns changes then we can report on it really.” (Group 2, participant 5) “Few studies have been done in this
area and the other side is that people are not actually looking for it to quantify the disease burden.” (Group 2,
participant 4)

(a)Target population

“Every woman who is sexually active or every young girl who is growing up should be vaccinated to prevent it.
It is not only who is sexually active in some way you might get it in another way or another form which are
probably they may have a small percentage so somehow they might be vaccinated; everybody must be
vaccinated.” (Group 2, participant 1). “People with immunocompromising conditions like people living with
HIV (Group 1, participant 7). “Ladies or girls between the ages of 11 and 12 are most advised to get the
vaccinations, so at their adolescent age.(Group 1, participant 6)” “. . .The focus should be on the youth, when
you analyze sexual activeness with age categorization, you will see that youth dominates so if the vaccination
can target the youth I think it will be proper.” (Group 2, participant 5)

(b) Schedule dose

“The vaccination is called Gardasil and Cervarix. And it is given 3 doses, or the recommendation is that 3
doses should be given. The first dose is given within the first month and the second month you will be given
the next dose and six months from the first dose then you will be given the third dose. That is how they do it.
(Group 1, participant 9)

(c) Infectious status

“Anybody who is tested and is negative can be vaccinated” (Group 2, participant 9) “I don’t understand what
you are saying because you can’t just vaccinate someone without doing the pap smear first,. how are you
going to make sure that the person is positive or negative. They need to be tested first before the vaccine and if
they are positive we don’t give them the vaccine” (Group 1, participant 8).

(d) Age eligibility (e) Vaccine
importance

“I support the initial concept that people could be vaccinated at birth, in that way once you are born and you
have immunity to the HPV. At birth, you have the vaccination to protect.” (Group 2, participant 4) “So
teenagers have become sexually active, so if we are to vaccinate, it’s better to start from the secondary schools,
even possibly the junior secondary schools here.” (Group 3, participant 1) “It’s important because it protects
for a lifetime. If you are being vaccinated with three doses, it means you are protected from the HPV virus for
a lifetime.” (Group 1, participant 2)“When you are being infected by this virus, the likelihood of you getting
cancer is high. So it is very important to get vaccinated to stay away from cancer and all the others.” (Group
3, participant 4)

2. HPV Vaccination
Knowledge

3. Initiation of
communication
Education & Counseling
(a) Hospital visit

“. . . those of us at the family planning center, when someone comes there, we normally do education, health
education for them. . . . We talk about it as the virus, how it occurs and how it causes cervical cancer and then
the pap smear as well.” (Group 1, participant 9).

(b) Positive status

“The pap smear will let the person go and get the vaccination, because if the person is sexually active then they
have to be tested before the vaccine. If they tested positive, they don’t get vaccination” (Group 1, participant
9).

Limited Vaccine Comm.
(c) Neglect

“It’s one of the conditions that we said it is neglected, we don’t focus on it. Because we don’t have data and I
don’t know what it is public health importance to authority. So once we don’t have an interest in that aspect
even education and awareness may not be done.” (Group 2, participant 6) “Sometimes the problem that we
are facing in the family planning now, people come in to do the pap smear but we don’t have the kits for seven
months to almost a year, we don’t have the kits. Look at this. We don’t have the kits for them to test whether
they are negative or positive before they go for the vaccine.” (Group 1, participant 9)

(d) Competing priorities

“It is not our priority. We have some diseases like malaria, HIV, TB that we focus on that. Like Ebola, those
that can cause pandemic or epidemic, the rest but for HPV it’s not our priority so we even don’t talk about it.”
(Group 2 participant 7)

(e) No data

“. . . if HPV is the lead contributory factor or is the only way one can get Cervical cancer, then our data is not
correct. . . ., we are using the ICD (International Classification of Disease) data to code all the ailments that
are reported here. So, if the doctors catering for such cases lump everything up and write CL of the service,
without giving us all the other contributing diagnosis or ailments . . ., then we also not report on HPV. So,
data in African and Ghana for that matter is something.” (Group 2, participant 5). “HPV I would say we
don’t know much or we don’t have much data on it. If we do it’s silent. It’s not like malaria or tuberculosis
whereby we can just click and get it.” (Group 1, participant 1)
(Continued )
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Table 2. (Continued)
Constructs

Themes

Quote

(f) Acute illness

“I think it’s because of the clinical situation. You know when the patients come your aim is to address the
condition they present with; so if it doesn’t go in that direction, it’s not likely that you bring that topic up.”
(Group 3, participant 2).

4. Participatory dialogue
Advantages
(a) Build immune system

“Your antibodies will be developed, and your immune system will be stronger to fight the virus.” (Group 2,
participant 5)

(b) Prevention

“From a social scientist's point of view, the vaccination, as you take it, it prevents the disease rather than to
wait for you to acquire the disease and then start treatment which is expensive.” (Group 1, participant 1) “To
protect you from a disease that is preventable. It is also to, you know, it protects the community depending on
the number of people who are vaccinated, even if someone comes into the system with the disease.” (Group 3,
participant 2)

Disadvantages

5. Behavioral
Confidence

(c) Stigma

You see, the stigma that comes with it, especially the things that- there is this notion that once you go for this
vaccine it means that you have the intention of either engaging in sexual activities or already doing so, people
stay away because of the stigma associated with it.” (Group 3, participant 10) “Some females wouldn’t want
their peers to know they are sexually active or they want to become sexually active. So in order not to let them
know, they wouldn’t even go for it in the first place.” (Group 3, participant 3)

(d) Religious objection

“Talking about churches, most churches will not encourage pre-marital sex. So they may see it as a means of
promoting immorality when you vaccinate adolescents and teenagers, they are seeing you as amoral and they
will not support it because of that.” (Group 3, participant 4).

(e) Discomfort/pain with
injection

“Every vaccine has its own way of making people uncomfortable or has its own side effects. It may make you
feel weak.” (Group 2, participant 1) “Not all patients like to be injected, in fact, the majority of patients would
avoid injections as much as possible . . . after the vaccination, it comes with so much pain that the arm will
hurt for quite a number of days so discomfort, it will deter people from getting vaccinated.” (Group 3,
participant 1)

(a) Predisposing

“We need to have access to information, how safe the drug is, the studies that have been done to evaluate the
safety and efficacy aspect of the drugs to convince myself that it is safe and efficacious, that is when I will give
it to others. So, the information about safety and side effects should be transparent.” (Group 2, participant 4)

(b) Enabling

“The parent consent will make me feel confident. The involvement of the parent in the child’s health will give
me the confidence to give HPV vaccination.” (Group 2, participant 2).
“I thinks it should be encouraged from the national level where there will be education from the national level
about the seriousness of the HPV and its health implications. Like HIV people are aware of its health
implications because of the involvement of national leaders and awareness created by the national media. So,
if we show on the TV the problem associated with HPV and the problem with cancer, I think people will
become aware. In most cases, people died of cervical cancer and they are not aware, and the family member
will be saying that the person was just sick and went to the hospital and just died but if we create awareness,
people will see the seriousness of the problems.” (Group 2, participant 3)

6. Physical Environment

(c) Reinforcing

“And, other people have come for the vaccine and it has worked very well for them. So that will give much
confidence in delivering any information about the vaccines to them.” (Group 2, participant 3) “Everything is
based on evidence and I can cite an issue whereby there is no evidence that the vaccine gives complications or
anything. So it is based on evidence. Even though many of them have been administered, you haven't heard of
any complications coming out of that so that confidence level is high and the vaccine is effective.” (Group 1,
participant 1)

(a) Structural

“The availability of the vaccines. If I educate somebody and if the vaccine is not there what are we going to
do? So, the vaccines should be available at reasonable prices before we even talk about education. (Group 2,
participant 2) “When you are able to get to these points of vaccination, you need to at least travel from one
point to the other. Your means of transport one and also the available roads and then the other means to get
to where you are going to do the vaccination is important because some people may be hindered because they
have to travel a long dusty road and by the end of the day they will be- their clothes will be filled with dust
and they will be tired; so they will not be encouraged to even attend even if you were to organize a
vaccination.” (Group 3, participant 7)

(b) Monetary

“I want to look at if from that the government will buy the vaccines and make it available to the ordinary
Ghanaians. The government can buy it, reduce the price or subsidize the price to let’s say 5 Ghana Cedis,[less
than $1.00 equivalent] that will help others to go for the vaccinations.Simply put, there is no widespread,
systematic, publicly available HPV vaccination program in Ghana to increase vaccination rates” (Group 2,
participant 5).
(Continued )
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Table 2. (Continued)
Constructs

7. Social Environment

Themes

Quote

(c) Administrative

“We need Facilities, personnel, monetary incentives, education and refresher courses. We need the human
personnel before you can initiate any move. Without human personnel, you cannot build the facilities and the
whatever. If you don’t have human personnel, it would be very difficult to champion any course.” (Group 1,
participant 9)

(a) Informational and tangible “We need support in the community and parents, we need ethical clearance (parental approval). . . . I would
support
say the social support that we need is parental contribution or support. And if we are doing it in the
community, we need to get one or 2 opinion leaders and explain for them to understand the issue. So if we
receive support from the community leaders it will help boost our morale to continue to offer education but
before we receive those opinion leaders' support they need to understand what the vaccination is all about. If
community leaders provide a platform by mobilizing the people for us to provide education to the masses.”
(Group 1, participant 1)
“In our communities, we hold the churches in high esteem so to involve them to be able to advocate for the
vaccine would be an advantage for the program.” (Group 3, participant 7).

8. Sustenance

“After I have given the injection, I will take the parents' phone number so that . . ., I will give them a call, . . .
to remind them that their child is due for their next injection. . . give them a small book to write the next date
for injection in it.” (Group 1, participant 9).

https://doi.org/10.1371/journal.pone.0240657.t002

The disadvantages include discomfort, pain with injection, unwanted side effects, religious
objection because it encourages engaging in immoral behaviors, and promoting promiscuity
objection, infertility, and stigma associated with the vaccination because others will assume
that individuals who are sexually active are the ones who will go for the HPV vaccine (4c-4e).
Behavioral confidence. On the HCPs’ sources of confidence for counseling or educating
teenagers and parents about the vaccination, three themes emerged. They were predisposing,
enabling and reinforcing factors. The predisposing factors include HCPs’ knowledge and
awareness about the efficacy of the vaccination (5a). HCPs mentioned that knowledge of the
source of the vaccine, efficacy of the vaccine, safety profile of the vaccine, and public awareness
of the seriousness of HPV could improve their confidence level for providing it to the client.
The enabling factors that could increase HCPs’ confidence in HPV vaccine education include
parental, community and national leaders’ involvement and support (5b). The participants
indicated parents’ involvement in the decision to vaccinate their children would motivate
them to give vaccinations or offer education. The level of moral support and trust HCPs
receive from the community and national leaders could influence HCPs to do more about
HPV vaccination and education. Reinforcing theme derived from the discussions include previous success from the HPV vaccination. Participants indicated that they would have the confidence to administer or talk to parents and adolescents about the vaccination if they know that
the vaccination works (5c).
Physical environment. Environmental factors that encourage or discourage the promotion of vaccine or vaccine education include structural and administrative supports. The structural factors include monetary (insurance and the cost of the vaccination), vaccines
availability, facilities, good roads and means of transportation to deliver the vaccine to the
community, incentives (snacks and refreshments) to attract people to vaccination centers, and
no widespread, systematic, publicly available HPV vaccination program in Ghana to increase
vaccination rates (6a-6b). The administrative variables include personnel, financial support,
and refresher education courses or additional training, availability of current information
about the vaccination, a reliable registry for HPV vaccination, and no national vaccination
program, (6c).
Social environment. HCPs indicated that the kind of social support needed includes
informational and tangible supports. Informational support includes parental approval. (7a).
They need support and involvement of opinion leaders including, assemblymen, pastors,
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imams, and chiefs in leading the HPV vaccination education efforts. This would boost the
HCPs’ morale to provide vaccine education and mobilize the community. However, they perceived that church involvement may be difficult since HPV vaccination may be thought of as
encouraging immoral behaviors. The HCPs reported that the use of media such as radio, TV
programs, and church gatherings could encourage them and the community for HPV vaccines. The tangible support they need include personnel, training and workshops, HPV vaccination kits, monetary incentives, and physically mobilizing the people in their communities
for vaccinations.
Sustenance. The methods HCPs indicated the methods used for ensuring completion of
the series of vaccination include the use of appointment reminder cards, phone calls a week
ahead of the next visit (8). They recommended the use of the motivated staff to volunteer (just
like patient navigators) to go to the communities to remind the people about their due dates.

Discussion
HPV-related cancers represent unmet medical needs in Ghana. HCPs’ role to facilitate HPV
vaccination to address this medical need cannot be underestimated. However, the attitudes
and behaviors of Ghanaian HCPs towards HPV vaccines have been understudied. Therefore,
guided by the multi-theory model (MTM), this study examined factors that influence the attitudes and behaviors of Ghanaian HCPs towards HPV vaccination. Additionally, we examined
HCPs’ knowledge about HPV vaccination, general recommendation/referral practices, and
how MTM constructs explain their general HPV vaccination practices. The key findings
included: general knowledge about HPV, gaps in knowledge about HPV vaccination and its
influence on HCPs’ HPV vaccination recommendation and education behaviors, and general
factors for increasing HPV vaccination in Ghana.
Similar to Hoque et al study among South African doctors, our findings show the HCPs
have a general understanding of the HPV mode of transmission and its health implications
[35]. Our study showed the HCPs have some basic knowledge about the HPV vaccination but
there were varied views and concerns about the recommended age eligibility for vaccination,
the availability, efficacy, and the safety of the vaccine. This finding supports Farias (2018)
study among Pediatricians who expressed concerns about HPV vaccine safety and efficacy
[36]. Our finding of lack of general HPV vaccination recommendations and counseling practice by HCPs is consistent with Suryadevara et al [37] study that concluded that pediatricians
in their study did not routinely recommend HPV vaccine to eligible patients. In particular, the
concept of "medical home” in which medical care is coordinated by a primary care physician is
not well integrated into the healthcare system in Ghana and many LMICs. Vaccines are provided through vaccination clinics or mobile clinics that are run by the government and delivered to communities. Therefore, HPV vaccination educations or referrals are normally done
by a few designated clinics. HCPs in our study also identified several other factors that impede
delivery of the HPV vaccine, including the competing health priorities such as malaria and
HIV; lack of surveillance data documenting the prevalence of the HPV related cancers, lack of
awareness about the causal relationship between persistent HPV infection and cervical cancer,
and confusion about the age eligibility and dosing schedule account for their low HPV vaccination counseling or recommendation in Ghana. Several studies including a systematic review
[38] have come to a similar conclusion that HCPs’ low knowledge of the vaccine [27,39–41],
and low-self-confidence [27,42] about HPV vaccination correspond with low vaccine recommendation rate [38]. Similarly, our study finding agrees with a few other studies that have
argued that confusing about age eligibility [28,43,44] and dosing schedule [45] contribute to
HCPs’ unwillingness to recommend or counsel parents and adolescents about the vaccination
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[38]. Another interesting finding is that HCPs reported the use of the HPV vaccination screening as a precondition for HPV vaccination. Individual’s positive status indicates that the person will not be vaccinated but only those who tested negative would be vaccinated. However,
in the high income countries like the US, the vaccine is recommended for individuals who are
within the specific age eligibility, regardless of the HPV infectious status [6,46] and that testing
or screening for HPV status is not recommended [47].
Multi-Theory Model (MTM) constructs were used to determine the factors that could
encourage HPV vaccination uptake. The Participatory dialogue construct discusses the reasons
for (advantages) and against (disadvantages) HPV vaccination. HCPs stated that the advantages of HPV vaccination include HPV virus prevention, the building of the immune system,
and the reduction of morbidity and mortality rates. They identified that the disadvantages of
HPV vaccination include discomfort, pain with injection, unwanted side effects, encourage
engaging in immoral behaviors and promoting promiscuity. Our findings support the conclusions of many studies that indicated that discomfort [41,48] and concerns that teens will practice risky sexual behavior affect their recommendation behaviors [37,38,42].
The behavioral confidence construct discusses factors that would build HCPs’ confidence
to recommend HPV vaccination. The key behavioral confidence factors HCPs identified
include an increase in awareness about the efficacy and safety of the vaccination, parental,
community and national leaders’ involvement and support for the vaccination. These findings
underscore that parents, community or opinion and national leaders support increases the
health care HCPs’ confidence in the general practices of HPV vaccination recommendations
[22,49,50].
The social environment construct determines social factors that could enhance the HCPs’
willingness to recommend HPV vaccination. Similar to factors identified under the behavioral
confidence construct, HCPs reported the involvement of opinion leaders including assemblymen, pastors, imams, and chiefs could increase the vaccination uptake and this finding substantiates Schmidt-Grimminger et al [41] study’s that opinion leaders e.g. fathers and
grandparents could be influential in the HPV vaccination decision making. HCPs also recognized that the use of communication channels such as Media radio, TV programs, and church
gatherings could encourage them. This finding agrees with Dilley et al [48] findings that the
use of media to educate could encourage HPV vaccinations.
The physical environment construct examines physical factors in the environment that
could contribute to the HCPs’ HPV vaccination recommendation practices. Consistent with
several studies, HCPs in our study identified monetary (insurance and the cost of the vaccination) factors, vaccines availability, good roads and means of transportation to deliver the vaccine to the community, personnel [26,36,48] and refresher educational courses or additional
training [22,51], as physical environmental factors that could increase the HPV vaccination.
Sustenance construct discusses the best practices that HCPs could use to get parents and
adolescents to complete the recommended series of the HPV vaccination. The HCPs in our
study listed phone calls, text messages and sending volunteers to remind parents and adolescents could increase HPV vaccination. Hudson et al studies show that HCPs use of reminders
such as text messages, phone calls, and prompts can improve HPV vaccine completion rates,
and some HPV vaccination interventions that included parental reminders have succeeded
[52].

Limitations and strengths
The goal of this study was to gain a more in-depth understanding of HCPs’ perceptions of
HPV vaccination and provide insight into ways the provider may be able to increase vaccine
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uptake. We acknowledge that the types of HCPs who participated in our focus groups limits
the generalizability of our findings. Specifically, HCPs were recruited from the Komfo Anokye
Teaching Hospital and the Ghana Health Services, and their perceptions may not be representative of other HCPs, such as those working in rural settings and community clinics Additionally, inclusion of the health professional such as health administrators, biostatisticians and
pharmacists, who do not directly provide service to patients was a limitation because for the
most part they were not able to contribute well when we were discussing communication of
HPV vaccination to parents and adolescents. The face-to-face nature of the focus group discussion presents several challenges including socially desirable responses. Another limitation of
focus groups is the potential for the domination of the discussions by the most outspoken
HCPs, and uncomfortable feeling from some of the introvert HCPs and may refuse to talk
about their experiences. To control for possible socially desirable responses, we assured the
participants that their individual responses would be kept in strict confidence and all study
information would be de-identified. We conducted the focus group discussions in a roundrobin format to give every participant the opportunity to talk.
Despite the noted limitations, our findings provide valuable insight into the HPV vaccination process in Ghana. First, this study helps us to determine the challenges of and motivations
for HPV vaccination from low- and middle-income country HCPs who are not only underrepresented in the discourse of the HPV vaccination but also are hard to reach individuals. Second, the use of MTM to guide the study is important because MTM constructs—participatory
dialogue [53], behavioral confidence [54,55], social environment, physical environment
[54,56], and emotional transformation [57] have been empirically tested and proven to be efficacious in guiding studies. Finally, the inclusion of other health care professionals (administrators, biostatisticians, pharmacist) other than providers with direct contact with patients shows
the strength of the study for two reasons. (a) This study is first of its kind in Ghana and the
administrators, biostatisticians, pharmacist provided information about the logistical, administrative, and facilities challenges to HPV vaccination in Ghana. For instance, the biostatisticians discussed the lack of epidemiological data (i.e. incidence, prevalence) on HPV infection
and cervical cancer cases, the pharmacist contributed immensely about the concern of the efficacy, safety and the availability of the vaccine (b) The inclusion of community fieldworkers
from Ghana Health Services provided perspectives from an institution which is in charge of
the distribution of HPV vaccination in Ghana. The community fieldworker provided much
information about going to communities to provide vaccinations to adolescents and the kind
of challenges they face.

Implications
The findings of this study have several implications. We observed divergent views about HPV
vaccination age eligibility, schedule doses, the target populations, and the HPV infection status. This finding underscores the need for HCPs-specific education and communication training. Specifically, interventions program or HPV vaccination educational training on the
World Health Organization recommendations for HPV vaccinations that include two doses of
vaccination for 9 to 14-year-olds [3,7–10] and three doses for both males and females aged 15
through 26 who have not been previously vaccinated [11]. HCPs’ knowledge about the safety
of the vaccine is low so intervention to increase knowledge about the safety and efficacy of the
vaccine and to equip HCPs with strategies to communicate about the vaccine could help build
the confidence of HCPs to counsel parents and adolescents. Proper surveillance data documenting the prevalence and incidence of the disease could be used to advance an argument to
support the reprioritization of HPV vaccination as an important public health priority. To
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address the stigma about the vaccination, an intervention to reframe the conversation about
the vaccination as cancer prevention may help. This was underscored by our findings that
HCPs often discussed the sexual nature of HPV, tied the initiation of the vaccine series to sexual debut, and expressed that parents of their patients were concerned with the potential sexual
implications of the vaccine. An intervention designed to increase HPV vaccination should
include the involvement of churches, the political and community leaders to counter the current narrative connecting the HPV vaccine and sexual behavior. MTM constructs including
participatory dialogue, behavioral confidence, changes in the physical environment, social
environment, and sustenance could be used to guide intervention to educated HCPs in Ghana.

Conclusion
The findings of our study underscore the need for a comprehensive HPV vaccination educational or intervention program in Ghana. The program should be designed to (a) equip health
care HCPs and the community with knowledge about the efficacy of HPV vaccination to prevent cancer, (b) address transportation issues for both vaccination delivery and access, and (c)
address HPV vaccination-related stigma to increase vaccination uptake. This comprehensive
program is critical as the health workers will be armed with the right information to educate
the public, dispel misconceptions and promote the uptake of the vaccine. Ultimately, this will
be a giant step forward in Ghana’s attempt at cervical cancer prevention and control.
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